BOOM
Recent additions may not be included but will usually appear in 24 hrs or less.
| Rational | Source |
|---|---|
|
Effects of Mexican Ganoderma lucidum extracts on liver, kidney, and the gut microbiota of Wistar rats: A repeated dose oral toxicity study. ✅
Go to Publication ✅
PloS one (PLoS One ) Vol: 18 Issue 4 Pages: e0283605 Pub: 2023 Epub: 2023 Apr 6 Authors Meneses ME , Martínez-Carrera D , González-Ibáñez L , Torres N , Sánchez-Tapia M , Márquez-Mota CC , Rendón G , Mitzi V , Morales A , Tello-Salgado I , Tovar AR , |
|
|
Effects of Mexican Ganoderma lucidum extracts on liver, kidney, and the gut microbiota of Wistar rats: A repeated dose oral toxicity study. ✅
Go to Publication ✅
PloS one (PLoS One ) Vol: 18 Issue 4 Pages: e0283605 Pub: 2023 Epub: 2023 Apr 6 Authors Meneses ME , Martínez-Carrera D , González-Ibáñez L , Torres N , Sánchez-Tapia M , Márquez-Mota CC , Rendón G , Mitzi V , Morales A , Tello-Salgado I , Tovar AR , |
|
|
A polysaccharide isolated from Ganoderma lucidum ameliorates hyperglycemia through modulating gut microbiota in type 2 diabetic mice. ✅
Go to Publication ✅
International journal of biological macromolecules (Int J Biol Macromol ) Vol: 197 Issue Pages: 23-38 Pub: 2022 Feb 1 Epub: 2021 Dec 15 Authors Shao W , Xiao C , Yong T , Zhang Y , Hu H , Xie T , Liu R , Huang L , Li X , Xie Y , Zhang J , Chen S , Cai M , Chen D , Liu Y , Gao X , Wu Q , |
|
|
Mexican Ganoderma Lucidum Extracts Decrease Lipogenesis Modulating Transcriptional Metabolic Networks and Gut Microbiota in C57BL/6 Mice Fed with a High-Cholesterol Diet. ✅
Go to Publication ✅
Nutrients (Nutrients ) Vol: 13 Issue 1 Pages: Pub: 2020 Dec 24 Epub: 2020 Dec 24 Authors Romero-Córdoba SL , Salido-Guadarrama I , Meneses ME , Cosentino G , Iorio MV , Tagliabue E , Torres N , Sánchez-Tapia M , Bonilla M , Castillo I , Petlacalco B , Tovar AR , Martínez-Carrera D , |
|
|
Intake of Ganoderma lucidum polysaccharides reverses the disturbed gut microbiota and metabolism in type 2 diabetic rats. ✅
Go to Publication ✅
International journal of biological macromolecules (Int J Biol Macromol ) Vol: 155 Issue Pages: 890-902 Pub: 2020 Jul 15 Epub: 2019 Nov 9 Authors Chen M , Xiao D , Liu W , Song Y , Zou B , Li L , Li P , Cai Y , Liu D , Liao Q , Xie Z , |
|
|
Effects of Ganoderma lucidum polysaccharides on chronic pancreatitis and intestinal microbiota in mice. ✅
Go to Publication ✅
International journal of biological macromolecules (Int J Biol Macromol ) Vol: 93 Issue Pt A Pages: 904-912 Pub: 2016 Dec Epub: 2016 Sep 9 Authors Li K , Zhuo C , Teng C , Yu S , Wang X , Hu Y , Ren G , Yu M , Qu J , |
|
|
Hypocholesterolemic Properties and Prebiotic Effects of Mexican Ganoderma lucidum in C57BL/6 Mice. ✅
Go to Publication ✅
PloS one (PLoS One ) Vol: 11 Issue 7 Pages: e0159631 Pub: 2016 Epub: 2016 Jul 20 Authors Meneses ME , Martínez-Carrera D , Torres N , Sánchez-Tapia M , Aguilar-López M , Morales P , Sobal M , Bernabé T , Escudero H , Granados-Portillo O , Tovar AR , |
|
|
Regulatory effect of Ganoderma lucidum and its active components on gut flora in diseases. ✅
Go to Publication ✅
Frontiers in microbiology (Front Microbiol ) Vol: 15 Issue Pages: 1362479 Pub: 2024 Epub: 2024 Mar 18 Authors Qin X , Fang Z , Zhang J , Zhao W , Zheng N , Wang X , |
|
|
Regulatory effect of Ganoderma lucidum and its active components on gut flora in diseases. ✅
Go to Publication ✅
Frontiers in microbiology (Front Microbiol ) Vol: 15 Issue Pages: 1362479 Pub: 2024 Epub: 2024 Mar 18 Authors Qin X , Fang Z , Zhang J , Zhao W , Zheng N , Wang X , |
|
|
Combined Ganoderma lucidum polysaccharide and ciprofloxacin therapy alleviates Salmonella enterica infection, protects the intestinal barrier, and regulates gut microbiota. ✅
Go to Publication ✅
Food & function (Food Funct ) Vol: 14 Issue 15 Pages: 6896-6913 Pub: 2023 Jul 31 Epub: 2023 Jul 31 Authors Li M , Yu L , Zhai Q , Chu C , Wang S , Zhao J , Zhang H , Tian F , Chen W , |
|
|
Combined Ganoderma lucidum polysaccharide and ciprofloxacin therapy alleviates Salmonella enterica infection, protects the intestinal barrier, and regulates gut microbiota. ✅
Go to Publication ✅
Food & function (Food Funct ) Vol: 14 Issue 15 Pages: 6896-6913 Pub: 2023 Jul 31 Epub: 2023 Jul 31 Authors Li M , Yu L , Zhai Q , Chu C , Wang S , Zhao J , Zhang H , Tian F , Chen W , |
|
|
Modulation of gut microbiota and lipid metabolism in rats fed high-fat diets by Ganoderma lucidum triterpenoids. ✅
Go to Publication ✅
Current research in food science (Curr Res Food Sci ) Vol: 6 Issue Pages: 100427 Pub: 2023 Epub: 2022 Dec 27 Authors Tong A , Wu W , Chen Z , Wen J , Jia R , Liu B , Cao H , Zhao C , |
|
|
An integrated microbiome and metabolomic analysis identifies immunoenhancing features of Ganoderma lucidum spores oil in mice. ✅
Go to Publication ✅
Pharmacological research (Pharmacol Res ) Vol: 158 Issue Pages: 104937 Pub: 2020 Aug Epub: 2020 May 26 Authors Wu X , Cao J , Li M , Yao P , Li H , Xu W , Yuan C , Liu J , Wang S , Li P , Wang Y , |
|
|
Ganoderma lucidum polysaccharides target the gut-brain axis: Unveiling a novel mechanism for ameliorating aging-induced cognitive impairment and oxidative stress. ✅
Go to Publication ✅
International journal of biological macromolecules (Int J Biol Macromol ) Vol: Issue Pages: 149519 Pub: 2025 Dec 7 Epub: 2025 Dec 7 Authors Chen Y , Zeng X , Gong X , Chen Y , Zhang X , Luo S , |
BOOM
All suggestions are computed solely on their predicted microbiome impact. Safety, side-effects etc must be evaluated by your medical professionals before starting. Some items suggests have significant risk of adverse consequences for some people.
Special thanks to David F Morrison and Geert Van Houcke for doing Quality Assurance. Special thanks to Oliver Luk, B.Sc. (Biology) from BiomeSight for spot checking the coding of data from the US National Library of Medicine
This is an Academic site. It generates theoretical models of what may benefit a specific microbiome results.
Copyright 2016-2023 Lassesen Consulting, LLC [2007], DBA, Microbiome Prescription. All rights served.
Permission to data scrap or reverse engineer is explicitly denied to all users. U.S. Code Title 18 PART I CHAPTER 47 § 1030, CETS No.185, CFAA
Use of data on this site is prohibited except under written license. There is no charge for individual personal use. Use for any commercial applications or research requires a written license.
Caveat emptor: Analysis and suggestions are based on modelling (and thus infererence) based on studies. The data sources are usually given for those that wish to consider alternative inferences. theories and models.
Inventions/Methodologies on this site are Patent Pending.
Microbiome Prescription do not make any representations that data or analyses available on this site is suitable for human diagnostic purposes, for informing treatment decisions, or for any other purposes and accept no responsibility or liability whatsoever for such use.
This site is not Health Insurance Portability and Accountability Act of 1996 (HIPAA) compliant.
